Product NDC: | 54879-005 |
Proprietary Name: | Triacin-C |
Non Proprietary Name: | TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES AND CODEINE PHOSPHATE SYRUP |
Active Ingredient(s): | 10; 30; 1.25 mg/5mL; mg/5mL; mg/5mL & nbsp; TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES AND CODEINE PHOSPHATE SYRUP |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54879-005 |
Labeler Name: | STI Pharma LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA088704 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130101 |
Package NDC: | 54879-005-16 |
Package Description: | 473 mL in 1 BOTTLE, PLASTIC (54879-005-16) |
NDC Code | 54879-005-16 |
Proprietary Name | Triacin-C |
Package Description | 473 mL in 1 BOTTLE, PLASTIC (54879-005-16) |
Product NDC | 54879-005 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES AND CODEINE PHOSPHATE SYRUP |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20130101 |
Marketing Category Name | ANDA |
Labeler Name | STI Pharma LLC |
Substance Name | CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE |
Strength Number | 10; 30; 1.25 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |